Connect with us

BUSINESS

Acreage Holdings Inc (OTCMKTS: ACRHF) Appoints New Executive Vice President of Government Relations, and Dr. Sigal Tavor (MD) Joins Cannabics Pharmaceuticals Inc (OTCMKTS: CNBX) Board of Advisors

Published

on

Acreage Holdings Inc (OTCMKTS: ACRHF) has appointed Bryan Murray as Executive Vice President of Government Relations, it is learned. The appointment stands effective from August 23. 

CEO of the company looking forward to working with Murray

Meanwhile, Peter Caldini, Chief Executive Officer Acreage Holdings Inc, said that he is confident that Murray’s leadership skills can help build long-term collaborative relationships with government officials, regulators, and partners at the local, state, and national levels. The CEO believes it can go a long way in enhancing cannabis legislation. 

The group’s CEO went on record and stated that Murray has to his credit more than a decade of experience in the policy and regulatory sector while serving at Pfizer. Caldini added that he is confident that Murray can partner with essential policymakers to bring sustainable results. 

Dr. Sigal Tavor (MD) taken as Board of Advisors for Cannabics Pharmaceuticals Inc (OTCMKTS: CNBX)

Cannabics Pharmaceuticals Inc (OTCMKTS: CNBX) has taken Dr. Sigal Tavor (MD) as its board of advisors. The development comes after an announcement made by the company to have included to its board of advisors Prof. Caroline Robert (MD, Ph.D.), a Melanoma expert along with Prof. Amos Toren (MD), Prof. Zamir Halpern (MD), Dr. Erez Scapa (MD), Dr. Dana Ben-Ami Shor (MD), Dr. Sigalit Arieli-Portnoy (Ph.D.) and Dr. Tal Mofkadi (Ph.D.). Additionally, it is learned that the official announcement was made after the company announced that it had expanded its Board of Directors. It is known that Dr. Inbar Maymon-Pomeranchik (Ph.D.) and Dr. Gil Feiler (Ph.D.) have joined the group as Independent Directors. 

Dr. Tavor will work towards improving the drug discovery platform of the company

The appointment of Dr. Tavor as Board of Advisors is a part of the group’s initiative to enhance its drug discovery platform and research abilities. The company will focus on its ongoing cancer programs besides focusing on Hematology. A source from the group shared that it will not stop the production process of its new drug candidates for additional indications.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

BUSINESS

Marc Lustig, Who Owns Over 1 million Common Shares Appointed To Briacell Therapeutics Corp (NASDAQ: BCTX) Board of Directors and Pharmacielo Ltd (CVE: PCLO) to Appoint Veterans to Board

Published

on

Brickell Therapeutics Corp (NASDAQ: BCTX) is back in the news. The company has appointed Marc Lustig to its board of directors. The appointment is effective from September 1 onwards. In addition, it is learned that Lustig currently owns more than 1 million common shares of Briacell Therapeutics Corp through his investment firm L5 Capital Inc.

Reactions pour in as news of the new addition was made official

Stating that the appointment of Lustig to the board of directors comes at a time when the company is in its transformative phase, Bondarenko, Chairman of the Board of Briacell Therapeutics Corp added that Lustig’s expertise in both corporate finance and the pharmaceutical sector is an asset for the company. Meanwhile, Lustig stated that the company is armed with the technology to change how cancer is treated. The clinical-stage biotechnology company specializes in targeted immunotherapies for advanced breast cancer. 

Pharmacie Ltd (CVE: PCLO) will have onboard Cannabis industry veterans

Pharmacie Ltd (CVE: PCLO) has announced that the company will appoint cannabis industry veterans, namely Bob DeGabrielle and Will Nicholas, to the company’s board. It is learned that DeGabrielle, an entrepreneur, also served as an executive in the U.S. cannabis industry. According to reports, the cannabis industry veteran has decided to sell Los Sueños Farms LLC to Curaleaf, Inc. Meanwhile, Nicholas, also a veteran in the cannabis industry, was one of the founding shareholders of Alternative Medical Enterprises LLC, which in December 2020 merged with Verano Holdings LLC. 

About the board of directors of Pharmacielo Ltd

The board of directors of Pharmacielo Ltd includes a mix of highly talented and skilled professionals who have the relevant expertise and experience in their respective fields of work. Headquartered in Canada, the company is involved in the processing and supplying medical and natural cannabis oil extracts, related products, and by-products to its extensive chain of distributors. 

Chairman and CEO of Pharmacielo Ltd happy with the appointments 

Stating that the company aims to take one of the most extensive lowest-cost cannabis operations globally besides becoming the leaders in the sector, Bill Petron, Chairman, and CEO of the group, stated that the company has the right talented people to do so. 

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

OrganiGram Holdings Inc(NASDAQ: OGI) Extends Popular SHRED Product Portfolio with SHRED’ems Gummies and SpeakEasy Receives Amendment to its Sales license

Published

on

A leading producer of Canadian-based cannabis company, OrganiGram Holdings Inc(NASDAQ: OGI), announced the launch of high SHRED’ems, high quality, innovative, and flavored cannabis gummies. Moreover, SHRED’ems is the lineup of the company’s highly popular portfolio product, which includes a SHRED jar of joints and SHRED milled flower. Already, SHRED’ems acquired great momentum by capturing the leading market share since its launch in early August in the PEI category within two weeks of launch. It also reached the fourth position in New Brunswick. 

By reflecting the SHRED’s portfolio, the innovative and convenience SHRED’ems is expected to be one of the best gummies on the market in terms of price and competition. Furthermore, SHRED’ems are available in all-natural and three bold flavors, which include ‘wild berry blaze,’ a blend of blueberry and raspberry. Wildberry blaze is available in four gummies packages. In addition, ‘Sour cherry punch,’ is available in 2 gummies package with tart and tangy-sweet. Finally, ‘Sour mega melon,’ is available in watermelon flavor and contains a package of 2 gummies. These gummies are the Organigram’s first products to be manufactured by the Edibles & Infusions Corp. In April 2021, the Organigram acquired the EIC. 

SpeakEasy Receives Amendment to its Sales Licence

Leading cannabis cultivating and selling company, SpeakEasy, announced that the company received an amendment to its sales license on September 2, 2021. SpeakEasy has a license from Health Canada that allows the edibles, sales of concentrates directly to recreational markets and medical in Canada. Now, the sales amendment of Speakeasy’s license includes an authorization for the company to sell more classes of cannabis by Health Canada. 

Moreover, the amendment lets SpeakEasy sell potent edibles, extracts, and topicals directly into the medical and recreational markets. In addition, the amendment allows shipping products from the country. 

Marc Geen’s Statement

Founder of SpeakEasy, Marc Geen, stated that being vertically integrated to be efficient and price-effective has been the company’s major goal from the beginning. The amendment is a major milestone for the company. SpeakEasy is now ready to bring its high-quality products with an efficient price range directly to the medical patients and markets.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

BUSINESS

Terrascend Corp (OTCMKTS: TRSSF) Signed an Agreement to Acquire Gage Cannabis and Increases ownership of the New Jersey License

Published

on

Terrascend Corp (OTCMKTS: TRSSF) signed an agreement with Gage Growth, a leading premium high-quality cannabis brand, to acquire all the outstanding subordinate shares under Canada Business Act. By the definitive agreement of North American leading cannabis operator, Terrascend, the shareholders of Gage Growth will acquire 0.3001 common shares. The total exchange ratio is represented as $545 million based on the company’s closing price on August 31, 2021. Moreover, completion of the transaction will lead the combined business operations in 5 states and seven cultivation facilities, including 23 dispensaries in both adult-use and medical cannabis in markets of Canada and the U.S. 

Management Statement

Executive Chairman of TerrAscend, Jason Wild, said that the acquisition of Gage expands their standard to the third-largest cannabis organization in the U.S. Also, combing TerrAscend with Gage’s successful cultivation, marketing capabilities, retail makes one of the dynamic and largest companies in the market. Moreover, TerrAscend anticipates leveraging Gage’s connections with Michigan’s consumers and its partners with award-winning brands like ‘cookies’ to offer their patients and consumers the best class products and retail experiences. 

In addition, the chief executive officer of Gage Growth, Fabin Monaco, said that Gage’s and TerrAscend’s corporate values and strategies make the combination a strong fit. Gage believes that the agreement with TerrAscend is the best choice to execute their plan of vertical integration and scale in their core markets. 

TerrAscend Increases Ownership of Jew Jersey License Ahead of Adult-Use

On August 20, TerrAscend completed the acquisition of TerrAscend New Jersey from BWH New Jersey and Blue Marble Ventures with an additional 12.5% of the outstanding equity. In addition, the transaction closed for an initial cash payment of $25 million comprised of TerrAscend shares and cash to be paid within the end of the year. Finally, TerrAscend currently owns 87.5% of the outstanding and issued shares of TerrAscend NJ. 

Moreover, TerrAscend will have a choice to acquire an additional 6.25% of the TerrAscend NJ’s issued and outstanding shares at a pre-determined valuation during the time starts from April 1, 2023, through June 15, 2023. 

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Continue Reading

Trending Stories